|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
17.520 -0.880 (-4.783%) | 2022/12 - Final RMB(K¥) | %Chg (Final to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 43,811,385 | 12.729% | 38,864,174 | 30,163,260 | 28,389,277 | 24,713,875 | |
| Cost of Sales | (23,169,690) | 14.533% | (20,229,785) | (13,733,529) | (11,543,421) | (10,365,309) | |
| Gross Profit | 20,641,695 | 10.772% | 18,634,389 | 16,429,731 | 16,845,856 | 14,348,566 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (65,369) | -11.683% | (74,016) | (104,836) | (97,114) | (27,162) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 1,835,146 | 2.572% | 1,789,137 | 1,580,335 | 1,431,414 | 1,348,997 | |
| Profit / (Loss) before Taxation | 4,580,552 | -24.197% | 6,042,670 | 4,677,846 | 4,525,753 | 3,579,593 | |
| Taxation | (626,918) | -41.212% | (1,066,401) | (737,865) | (782,231) | (559,711) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (216,659) | -12.482% | (247,558) | (277,168) | (421,904) | (311,959) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 3,736,975 | -20.973% | 4,728,711 | 3,662,813 | 3,321,618 | 2,707,923 | |
| Net Finance Costs / (Income) | 681,172 | 15.697% | 588,755 | 681,343 | 888,042 | 783,920 | |
| Depreciation & Amortisation | 2,447,605 | 25.618% | 1,948,448 | 1,728,137 | 1,520,479 | 1,346,916 | |
| Directors' Emoluments | -- | -- | 39,627 | 31,033 | 26,864 | 25,351 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 143.000 | -- | 185.000 | 143.000 | 130.000 | 107.000 |
| DPS (cts) | 42.000 | -- | 56.000 | 43.000 | 39.000 | 32.000 |
| Dividend Payout Ratio (%) | 29.371% | -- | 30.270% | 30.070% | 30.000% | 29.907% |
| Cash flow per share ($) | -- | -- | -- | 1.007 | 1.257 | 1.169 |
| NBV per share ($) | 16.665 | -- | 15.271 | 14.413 | 12.420 | 10.894 |
| Remarks: | Real time quote last updated: 03/10/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,783,642 |
| %Change | 14.814% |
| EPS / (LPS) | RMB 0.670 |
| NBV Per Share (¥) | RMB 16.996 |